Catherine M. Engelbert

Insider Reports History

Location
Chicago, IL
Signature
/s/ Jeffrey J. Pochowicz, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine M. Engelbert:

Company Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc Director Class A Ordinary Shares 51,128 $1,633,539 $31.95 13 May 2025 Direct
MCDONALDS CORP Director Phantom Stock 4,674 $1,428,511 $305.63 31 Dec 2025 Direct
Royalty Pharma plc Director Class A Ordinary Shares 43,514 $1,315,354 $30.23 07 Jun 2024 Direct
MCDONALDS CORP Director Common Stock 2,079 $647,047 $311.23 31 Dec 2025 Direct

Insider Reports Filed by Catherine M. Engelbert

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MCD MCDONALDS CORP 31 Dec 2025 1 +$205,001 4 Director 05 Jan 2026, 11:52
RPRX Royalty Pharma plc 13 May 2025 1 $0 4 Director 15 May 2025, 17:41
MCD MCDONALDS CORP 31 Dec 2024 1 +$203,059 4 Director 03 Jan 2025, 17:31
RPRX Royalty Pharma plc 07 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:12
MCD MCDONALDS CORP 31 Dec 2023 1 +$199,999 4 Director 03 Jan 2024, 16:12
RPRX Royalty Pharma plc 23 Jun 2023 1 $0 4 Director 26 Jun 2023, 16:05
MCD MCDONALDS CORP 03 Apr 2023 1 +$10,679 4 Director 04 Aug 2023, 17:55
MCD MCDONALDS CORP 31 Dec 2022 1 +$191,452 4 Director 04 Jan 2023, 13:46
RPRX Royalty Pharma plc 24 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:59
MCD MCDONALDS CORP 28 Feb 2022 1 +$244,180 4 Director 02 Mar 2022, 13:34
MCD MCDONALDS CORP 31 Dec 2021 1 +$185,000 4 Director 04 Jan 2022, 11:09
RPRX Royalty Pharma plc 25 Jun 2021 1 $0 4 Director 29 Jun 2021, 20:22